Drug General Information
Drug ID	D0Z2QR
Former ID	DNCL003425
Drug Name	DS-7250
Indication	Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1]		Discontinued in Phase 1	[549362]
Company	Daiichi Sankyo
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Diglyceride acyltransferase	Target Info	Modulator	[550585]
BioCyc Pathway	Triacylglycerol biosynthesis
KEGG Pathway	Glycerolipid metabolism
	Retinol metabolism
	Metabolic pathways
	Fat digestion and absorption
PathWhiz Pathway	Retinol Metabolism
Reactome	Acyl chain remodeling of DAG and TAG
	Triglyceride Biosynthesis
WikiPathways	Vitamin A and Carotenoid Metabolism
	Statin Pathway
	Triacylglyceride Synthesis
	Glycerophospholipid biosynthesis
	Fatty acid, triacylglycerol, and ketone body metabolism
References
Ref 549362	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035670)
Ref 550585	Clinical pipeline report, company report or official report of Daiichi Sankyo.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.